Israel and US-based Cheetah Medical has secured $9m series D fundraising led by Fletcher Spaght Ventures and including Robert Bosch Venture Capital and Ascension Health Ventures.
Fletcher Spaght Ventures, who have an extensive life science portfolio, led the round, which also saw participation from Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures.
Renard Charity of Fletcher Spaght Ventures, said: “We are enthusiastic about the need for and potential of the Cheetah Nicom technology as a fundamental improvement in patient care. The company is led by a strong management team and has an excellent investment syndicate of which…
